Enhancement of apoptosis in HCT116 and HepG2 cells by Coix lacryma-jobi var. lacryma-jobi seed extract in combination with sorafenib
The combination of CLCD with sorafenib demonstrates significant potential as a strategy for future anticancer therapies. This CL seed extract, cultivated and commercially available in Thailand, shows promise as a natural supplement to enhance the efficacy of chemotherapy in upcoming clinical anticancer applications.
Authors
- Piyarat Srisawang (ORCID: https://orcid.org/0000-0002-0948-8239)
- Suphunwadee Sawong
- Apirath Wangteeraprasert (ORCID: https://orcid.org/0000-0001-7592-5436)
- Pennapha Suknoppakit (ORCID: https://orcid.org/0000-0002-0393-4808)
- Supawadee Parhira (ORCID: https://orcid.org/0000-0002-2077-5888)
- Guo‐Yuan Zhu (ORCID: https://orcid.org/0000-0002-4355-894X)
- Dumrongsak Pekthong (ORCID: https://orcid.org/0000-0001-8965-3435)
- Julintorn Somran (ORCID: https://orcid.org/0000-0001-7158-0928)
- Naphat Kaewpaeng (ORCID: https://orcid.org/0009-0007-3596-5426)
- Khemmachat Pansooksan
Institutions
- Macau University of Science and Technology (MO)
- Quality Research (US)
- Naresuan University (TH)
Publication Details
- Journal
- Chinese Herbal Medicines
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1016/j.chmed.2025.02.005
- Primary Topic
- Microbial Metabolism and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00